Wattana Karnpaet PCL (BKK:NEW) Growth Rank: 6 (As of Sep. 21, 2026) — 33% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:NEW Wattana Karnpaet PCL BKK:NEW
81 GF Score
Price ฿92.75
GF Value ฿98.27
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Wattana Karnpaet PCL Growth Rank?

Wattana Karnpaet PCL BKK:NEW 81 Growth Rank is 6 as of Sep. 21, 2026, which is 33% below its 10-year median of 9.00. GuruFocus rates BKK:NEW with a GF Score™ of 81/100 and a GF Value™ of ฿98.27 (Fairly Valued). The stock has 2 warning signs investors should review.

Wattana Karnpaet PCL has the Growth Rank of 6.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Wattana Karnpaet PCL Growth Rank Related Terms

BKK:NEW vs HCA, THC, EHC: Growth Rank Comparison

For the Medical Care Facilities subindustry, Wattana Karnpaet PCL's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wattana Karnpaet PCL Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Wattana Karnpaet PCL's Growth Rank distribution charts can be found below:

* The bar in red indicates where Wattana Karnpaet PCL's Growth Rank falls into.


BKK:NEW
81GF Score
Wattana Karnpaet PCL BKK:NEW
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 6 mean?
Wattana Karnpaet PCL (BKK:NEW) has a Growth Rank of 6 as of Sep. 21, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Wattana Karnpaet PCL and its competitors. This is 33% below median its historical median of 9.00. Over the past decade, Wattana Karnpaet PCL's Growth Rank has ranged from 4.00 to 10.00.
Is Wattana Karnpaet PCL's Growth Rank too high?
Wattana Karnpaet PCL's current Growth Rank of 6 is 33% below median its 10-year median of 9.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 10.00. Overall, Wattana Karnpaet PCL has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Wattana Karnpaet PCL's Growth Rank compare to HCA and THC?
Wattana Karnpaet PCL's Growth Rank of 6 can be compared against companies in the Healthcare Providers & Services industry. Historically, Wattana Karnpaet PCL's own Growth Rank has ranged from 4.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Wattana Karnpaet PCL and its competitors. Wattana Karnpaet PCL's current Growth Rank is 6, which is 33% below median its own 10-year median of 9.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wattana Karnpaet PCL stock overvalued right now?
Based on GuruFocus' analysis, Wattana Karnpaet PCL (BKK:NEW) is currently considered Fairly Valued. The stock's GF Value™ is ฿98.27, compared to a current price of ฿92.75 — trading 5.6% below its estimated fair value. The current Growth Rank is 6, which is 33% below median its 10-year median of 9.00. Wattana Karnpaet PCL's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Wattana Karnpaet PCL (BKK:NEW), the current Growth Rank is 6 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Wattana Karnpaet PCL (BKK:NEW) Overvalued in 2026?

Based on GuruFocus' analysis, Wattana Karnpaet PCL stock appears to be undervalued. The current stock price of ฿92.75 is trading 5.6% below its estimated GF Value™ of ฿98.27. GuruFocus considers Wattana Karnpaet PCL to be Fairly Valued.

Key valuation signals for BKK:NEW:

  • Growth Rank: 6 (33% below median its 10-year median of 9.00)
  • GF Value™: ฿98.27 vs. price of ฿92.75 (5.6% below fair value)
  • GF Score™: 81/100 with 2 warning signs

No single metric tells the full story. See the BKK:NEW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Wattana Karnpaet PCL Business Description

Address 70/7-8 Suphakitjanya Road, Mhakkang sub-district, Muang Udonthanee district, Udonthanee, THA, 41000
Wattana Karnpaet PCL is engaged in the operation of a hospital under the name North Eastern Wattana Hospital. It has a single segment of operation, namely the hospital and medical trading business. The company earns revenue from hospital, revenue from sales of medicines, and revenue from hospital rooms, which are derived from the provision of services to various types and a large number of customers. Geographically, the company's operations are carried out in Thailand.
81GF Score

Get the complete analysis for BKK:NEW

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿92.75
Price
฿98.27
GF Value